2023
Exports
$45.3MWorld Rnk 54 / 208
Flag Rnk 102 / 1151
2023
PRODUCT COMPLEXITY IN Vaccines, blood, antisera, toxins and cultures
1.25Rnk 89 / 1025
2023
Imports
$341MWorld Rnk 59 / 222
Flag Rnk 30 / 1190
2023
ECONOMIC COMPLEXITY of Ukraine
0.39Rnk 47 / 132

About

Exports In 2023, Ukraine exported $45.3M in Vaccines, blood, antisera, toxins and cultures, making it the 54th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 102nd most exported product in Ukraine. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Ukraine are: Kazakhstan ($9.43M), Uzbekistan ($4.92M), Brazil ($3.99M), Iraq ($3.42M), and Georgia ($2.93M).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Ukraine between 2022 and 2023 were Georgia ($2.52M), Iraq ($2.45M), and Yemen ($1.31M).

Imports In 2023, Ukraine imported $341M in Vaccines, blood, antisera, toxins and cultures, becoming the 59th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 30th most imported product in Ukraine. Ukraine imports Vaccines, blood, antisera, toxins and cultures primarily from: Ireland ($51.8M), Germany ($32.4M), United States ($31M), Switzerland ($29.4M), and Hungary ($21.8M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Ukraine between 2022 and 2023 were Ireland ($22.2M), Hungary ($9.84M), and Azerbaijan ($9.35M).

Latest Trends

Jan 2025

Subnational Monthly Trade

View
Flow
Y-AXIS SCALE

For a full breakdown of trade patterns, visit the trend explorer or the product in country profile.

The following visualization shows the latest trends on Vaccines, blood, antisera, toxins and cultures. Countries are shown based on data availability.

* Using January 2020 exchange rates when trade data is reported in local currency.

Explore Latest Trends

Subscribe today to OEC pro and access the latest data

Sign Up

Historical Data

Trade Balance

Color
EXPORTS (2023)$45.3M
IMPORTS (2023)$341M
NET TRADE (2023)-$295M

In 2023, Ukraine exported $45.3M in Vaccines, blood, antisera, toxins and cultures. The main destinations of Ukraine exports on Vaccines, blood, antisera, toxins and cultures were Kazakhstan ($9.43M), Uzbekistan ($4.92M), Brazil ($3.99M), Iraq ($3.42M), and Georgia ($2.93M).

In 2023, Ukraine imported $341M in Vaccines, blood, antisera, toxins and cultures, mainly from Ireland ($51.8M), Germany ($32.4M), United States ($31M), Switzerland ($29.4M), and Hungary ($21.8M).

Explore Visualizations

Export Destinations (2023)

Import Origins (2023)

Market Growth

Flow
THE FASTEST GROWING Vaccines, blood, antisera, toxins and cultures EXPORT MARKETS FOR Ukraine WERE (2022 - 2023):
Georgia$2.52M (610%)
Iraq$2.45M (253%)
Yemen$1.31M (1%)
THE FASTEST DECLINING MARKETS FOR THE EXPORT OF Vaccines, blood, antisera, toxins and cultures BY Ukraine WERE (2022 - 2023):
Saudi Arabia-$8.92M (-91.3%)
Brazil-$3.95M (-49.8%)
Kazakhstan-$2.26M (-19.4%)

Change in Exports by Market (2022 - 2023)

Market Concentration

View
Flow
Type
In 2023, Ukraine's main exporting competitors in Vaccines, blood, antisera, toxins and cultures were:
In 2023, Ukraine's main importing competitors in Vaccines, blood, antisera, toxins and cultures were:

Explore Visualizations

Trade Value of Vaccines, blood, antisera, toxins and cultures by Exporters

Potential Exports

Potential Exports

Flow
View
TOP EXPORT POTENTIALBrazil+ $3.31M
TOP IMPORT POTENTIALGermany+ $24.6M

Vaccines, blood, antisera, toxins and cultures’s highest export potential is Brazil. With an export gap of $3.31M.   Vaccines, blood, antisera, toxins and cultures’s highest import potential is Germany with an import gap of $24.6M.

See methodology.

Subscribe today to OEC pro and access the latest data

Sign Up

Have questions, comments, or concerns?
Send us an e-mail: support@oec.world
Follow @OECtoday on
Created, Designed, and Developed by:
In collaboration with